300573 logo

Shenyang Xingqi Pharmaceutical Co.,Ltd. Stock Price

SZSE:300573 Community·CN¥13.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

300573 Share Price Performance

CN¥36.44
1.74 (5.02%)
CN¥36.44
1.74 (5.02%)
Price CN¥36.44

300573 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Outstanding track record with flawless balance sheet and pays a dividend.

1 Risk
2 Rewards

Shenyang Xingqi Pharmaceutical Co.,Ltd. Key Details

CN¥2.6b

Revenue

CN¥494.2m

Cost of Revenue

CN¥2.1b

Gross Profit

CN¥1.4b

Other Expenses

CN¥756.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
2.12
81.14%
28.87%
3.2%
View Full Analysis

About 300573

Founded
1977
Employees
2396
CEO
E. Gao
WebsiteView website
www.sinqi.com

Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, dry eye treatment medicines, mydriatics and cycloplegia drugs, miotics and anti-glaucoma drugs, and intraoperative intraocular irrigation fluids. It also engages in technology development, technical advice, eye hospital, and research and experimental development activities. Shenyang Xingqi Pharmaceutical Co.,Ltd. was founded in 1977 and is based in Shenyang, the People’s Republic of China.

Recent 300573 News & Updates

Recent updates

No updates